Opportunity Information: Apply for PA 11 009
Apply for PA 11 009
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233 National Center on Sleep Disorders Research 93.279 Drug Abuse and Addiction Research Programs 93.350 National Center for Advancing Translational Sciences 93.361 Nursing Research 93.389 National Center for Research Resources 93.398 Cancer Research Manpower 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research 93.859 Biomedical Research and Research Training.
- This funding opportunity was created on Nov 13, 2013 and posted on Oct 14, 2010.
- Applicants must submit their applications by Sep 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) (Funding Opportunity Number PA-11-009) is a National Institutes of Health mentored career development grant designed to build the next generation of patient-oriented clinical researchers who can operate comfortably at the intersection of pharmacogenomics and personalized medicine. The program recognizes a persistent gap in the workforce: there are too few investigators who are simultaneously trained in core clinical research competencies (the practical and methodological skills needed to design and conduct studies involving people) and in the modern scientific approaches required to tackle pharmacogenomics questions in real patient populations. In plain terms, NIH is using this mechanism to help clinicians and other patient-oriented researchers gain the specialized training, mentorship, and protected time needed to translate genomic and other individual-level information into better decisions about drug therapy, dosing, safety, and effectiveness.
This opportunity uses the NIH K23 mechanism, which is specifically aimed at mentored, patient-oriented research career development. The central benefit is salary support and protected time for research and training for up to five years, allowing an early-stage investigator to develop into an independent clinical researcher while continuing to build a coherent research program. A key expectation is that the award and its career development plan are not one-size-fits-all; each application should be tailored to the candidate, with a training plan and research plan shaped around the applicant’s background, gaps in expertise, and long-term goals in patient-oriented pharmacogenomics and personalized medicine. The award supports structured mentored development, meaning reviewers will look closely at how the candidate will acquire new skills, produce publishable patient-oriented research, and position themselves to compete for independent funding later on.
A defining feature of this particular K23 program is its required dual-mentoring structure. Applicants must have two mentors: one affiliated with the Clinical and Translational Science Awards (CTSA) consortium and another affiliated with the Pharmacogenomics Research Network (PGRN). This requirement is meant to ensure the scholar gets both sides of the training equation: strong grounding in clinical and translational research infrastructure and best practices through the CTSA environment, and deep, domain-specific guidance in pharmacogenomics through the PGRN community. The intent is to create investigators who can design rigorous patient-oriented studies while also applying state-of-the-art pharmacogenomic methods and thinking to real-world clinical questions.
In terms of funding, NIH indicated an estimated total program funding level of up to $1.5 million for the relevant fiscal year, with an anticipated number of approximately six awards (noting that final totals depend on the number, quality, duration, and cost of applications). The listed award ceiling is $200,000. As with many NIH opportunities, the final number of awards and exact funding distribution are contingent on application merit and available funds.
Eligibility is broad and includes a range of organization types that can serve as applicant institutions, such as public and private institutions of higher education, nonprofits with or without 501(c)(3) status, small businesses, and certain for-profit organizations (with additional eligibility details referenced in the full announcement). The opportunity explicitly includes institutions that serve historically underrepresented and special populations, including Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Hispanic-serving institutions, and Alaska Native and Native Hawaiian-serving institutions. There is no cost-sharing or matching requirement.
Administrative details in the source information show the opportunity was posted October 14, 2010, with closing dates listed in early and later 2014 and an archive date in October 2014, meaning the specific announcement as written is historical and no longer active; however, the description is still useful for understanding the goals and structure of this specialized K23 initiative. For full details, NIH provided an archived FOA link (http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html) and points of contact through the NIH Office of Extramural Research webmaster for access or technical issues.
FAQs: Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) - PA-11-009
What is the Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) program?
It is a National Institutes of Health (NIH) mentored career development program using the NIH K23 mechanism. It is designed to develop patient-oriented clinical researchers who can work at the intersection of pharmacogenomics and personalized medicine, with an emphasis on translating individual-level (including genomic) information into better medication decisions.
What is the Funding Opportunity Number (FON) for this program?
The Funding Opportunity Number is PA-11-009.
What type of grant mechanism does this opportunity use?
This opportunity uses the NIH K23 mechanism, which is a mentored career development award focused on patient-oriented research.
What problem is NIH trying to address with this K23 initiative?
The program targets a persistent workforce gap: too few investigators are trained both in core clinical research competencies (designing and conducting studies involving people) and in modern approaches needed to answer pharmacogenomics questions in real patient populations.
What kinds of research or career goals does this award support?
It supports career development for early-stage, patient-oriented researchers who want to translate genomic and other individual-level information into improved drug therapy decisions, including dosing, safety, and effectiveness, within real-world clinical research contexts.
What is the main benefit of the K23 award for a scholar?
The central benefit described is salary support and protected time for research and training for up to five years, enabling an early-stage investigator to develop toward independence while building a coherent patient-oriented research program.
How long can support last under this program?
Support can be provided for up to five years.
Is the career development plan the same for all applicants?
No. The expectation is that the application is tailored to the candidate. Both the training plan and research plan should be shaped around the applicant's background, identified gaps in expertise, and long-term goals in patient-oriented pharmacogenomics and personalized medicine.
What do reviewers focus on for this kind of mentored award?
Based on the description provided, reviewers are expected to look closely at how the candidate will acquire new skills, produce publishable patient-oriented research, and become positioned to compete for independent funding later.
What mentoring structure is required for this specific K23 program?
A dual-mentoring structure is required. Applicants must have two mentors: one affiliated with the Clinical and Translational Science Awards (CTSA) consortium and another affiliated with the Pharmacogenomics Research Network (PGRN).
Why are two mentors required (CTSA and PGRN)?
The intent is to ensure training on both sides of the equation: clinical and translational research infrastructure and best practices through the CTSA environment, along with domain-specific pharmacogenomics guidance through the PGRN community.
What kind of investigator is NIH trying to develop through this dual-mentoring approach?
The program aims to create investigators who can design rigorous patient-oriented studies while applying state-of-the-art pharmacogenomic methods and thinking to real clinical questions.
How much total funding did NIH estimate for the program in the relevant fiscal year?
NIH indicated an estimated total program funding level of up to $1.5 million for that fiscal year.
How many awards were anticipated?
Approximately six awards were anticipated, with the note that final totals depend on the number, quality, duration, and cost of applications.
What is the listed award ceiling?
The listed award ceiling is $200,000.
Are the final number of awards and funding amounts guaranteed?
No. As described, the final number of awards and the exact funding distribution are contingent on application merit and available funds.
What types of organizations are eligible to apply as applicant institutions?
Eligibility is described as broad and includes public and private institutions of higher education, nonprofits with or without 501(c)(3) status, small businesses, and certain for-profit organizations (with additional details referenced in the full announcement).
Does the opportunity include institutions serving historically underrepresented and special populations?
Yes. The description explicitly includes Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Hispanic-serving institutions, and Alaska Native and Native Hawaiian-serving institutions.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
Is this funding opportunity still active?
No. The administrative details indicate it was posted October 14, 2010, with closing dates in 2014 and an archive date in October 2014. That means the specific announcement (as written) is historical and no longer active.
Where can someone find the archived funding opportunity announcement?
An archived FOA link is provided: http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html
Who is listed as a point of contact for access or technical issues related to the announcement?
The information provided references points of contact through the NIH Office of Extramural Research webmaster for access or technical issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Partners for Fish and Wildlife Program
Previous opportunity: Comprehensive Partnerships to Reduce Cancer Health Disparities (U54)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 11 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006 Funding Number: PA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007 Funding Number: PA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV Infection of the Central Nervous System (R01) Apply for PA 11 014 Funding Number: PA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010 Funding Number: RFA RR 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008 Funding Number: RFA DA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026 Funding Number: PA 11 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010 Funding Number: RFA DA 11 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027 Funding Number: PA 11 027 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Continued Development and Maintenance of Software (R01) Apply for PAR 11 028 Funding Number: PAR 11 028 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Statistical Coordination Center for the Population based Research Optimizing Screening through Personalized Regimens (PROSPR)(U01) Apply for RFA CA 11 004 Funding Number: RFA CA 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Population based Research Optimizing Screening through Personalized Regimens (PROSPR) (U54) Apply for RFA CA 11 003 Funding Number: RFA CA 11 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R21) Apply for PA 11 034 Funding Number: PA 11 034 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R03) Apply for PA 11 035 Funding Number: PA 11 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 020 Funding Number: RFA RM 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Fogarty International Research Collaboration Behavioral and Social Sciences (FIRCA BSS) Research Award (R03) Apply for PAR 11 036 Funding Number: PAR 11 036 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 11 047 Funding Number: PA 11 047 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 11 048 Funding Number: PA 11 048 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 11 049 Funding Number: PA 11 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Extramural Research Facilities Improvement Program (C06) Apply for RFA RR 11 001 Funding Number: RFA RR 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
